The field of oncology is rapidly changing and evolving, with treatment becoming more precise and the speed of innovation compounding each year.

As more targeted therapies come to market, more patients have the hope of living a longer life. In this past record-setting year, more novel cancer medicines became available for the first time than in any year in history, and many of them employ immunology or precision biomarkers to transform the way patients are treated.

On this episode of Pharmacy Friends, we’re diving deep into precision medicine with Haita Makanji, Vice President of Clinical Strategy and Innovation at Prime, and Clynt Taylor, President of Trapelo. Trapelo offers the first, interoperable, decision-support platform used by oncologists, labs, and payers to inform testing and treatment, streamline workflow and facilitate real-time alignment in precision medicine.

Listen and learn how precision medicine be maximized to give cancer patients the best possible outcomes.

This episode is brought to you by the Prime Specialty Summit. After two years of virtual events, we're back in New York City, bringing you brilliant speakers, thought-provoking panels, in-person networking, and live music. Register now.